| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
·54 a comparison of methods for calculating a stratified kappa
|
Barlow, Bill
|
|
1990
|
11 |
4 |
p. 275-
1 p.
|
artikel
|
| 2 |
AIDS trials, civil rights, and the social control of therapy: Should we embrace new drugs with open arms?
|
Salisbury, Dick
|
|
1990
|
11 |
4 |
p. 258-
1 p.
|
artikel
|
| 3 |
Analysis by intent to treat: Is there really an option?
|
Lee, Young Jack
|
|
1990
|
11 |
4 |
p. 260-
1 p.
|
artikel
|
| 4 |
·55 analysis of interrater agreement on an ordered categorical scale
|
Melia, B.Michele
|
|
1990
|
11 |
4 |
p. 275-
1 p.
|
artikel
|
| 5 |
Analysis of longitudinal interval count data
|
Stukel, Therese A.
|
|
1990
|
11 |
4 |
p. 261-
1 p.
|
artikel
|
| 6 |
Analyzing the number of “rejection episodes” in human transplantation
|
Rochon, James
|
|
1990
|
11 |
4 |
p. 262-
1 p.
|
artikel
|
| 7 |
Announcement
|
|
|
1990
|
11 |
4 |
p. 232-
1 p.
|
artikel
|
| 8 |
Application of longitudinal data analysis in a clinical trial: The macular photocoagulation study
|
Maguire, Maureen G.
|
|
1990
|
11 |
4 |
p. 262-
1 p.
|
artikel
|
| 9 |
·56 Application of new two-sample tests to data from a randomized, placebo-controlled heart failure trial
|
Tandon, P.K.
|
|
1990
|
11 |
4 |
p. 276-
1 p.
|
artikel
|
| 10 |
A survey of data monitoring committees in NIH-sponsored multicenter trials
|
Hawkins, Barbara S.
|
|
1990
|
11 |
4 |
p. 273-
1 p.
|
artikel
|
| 11 |
Automating database changes following remote data entry: the BARI automated database update system
|
Carr, Mary Ann
|
|
1990
|
11 |
4 |
p. 271-
1 p.
|
artikel
|
| 12 |
Bayesian analysis of phase I clinical trials
|
Greenhouse, Joel B.
|
|
1990
|
11 |
4 |
p. 253-
1 p.
|
artikel
|
| 13 |
Benefit of early identification of ancillary hypotheses
|
Gordon, Mae E.
|
|
1990
|
11 |
4 |
p. 273-274
2 p.
|
artikel
|
| 14 |
Can observational studies ever replace the randomized clinical trial (RCT)? The case of coronary bypass surgery with the internal mammary artery (IMA) graft
|
Henderson, William
|
|
1990
|
11 |
4 |
p. 259-
1 p.
|
artikel
|
| 15 |
Chemoprevention: Challenges in design and conduct of cancer clinical trials
|
Vogel, Victor G.
|
|
1990
|
11 |
4 |
p. 269-
1 p.
|
artikel
|
| 16 |
Comparison of methods for analyzing paired survival data, with censoring
|
Hartigan, Pamela M.
|
|
1990
|
11 |
4 |
p. 266-
1 p.
|
artikel
|
| 17 |
Continual reassessment models in phase I clinical trials in cancer
|
O'Quigley, John
|
|
1990
|
11 |
4 |
p. 254-
1 p.
|
artikel
|
| 18 |
Continuation of the trial of antihypertensive interventions and management: Design features
|
Davis, B.R.
|
|
1990
|
11 |
4 |
p. 274-275
2 p.
|
artikel
|
| 19 |
Cost and quality of life outcomes in the TAMI 5 trial: The primacy of secondary endpoints
|
Melton, James
|
|
1990
|
11 |
4 |
p. 268-
1 p.
|
artikel
|
| 20 |
·57 Crossover trials in chronic disease
|
Walter, S.D.
|
|
1990
|
11 |
4 |
p. 276-
1 p.
|
artikel
|
| 21 |
Data monitoring through stochastic curtailing when the outcome proportions are small: An exact approach
|
Thomas, Ronald G.
|
|
1990
|
11 |
4 |
p. 264-
1 p.
|
artikel
|
| 22 |
Design issues in the measurement of quality of life in a trial of two prenatal diagnostic technologies: Genetic amniocentesis and chorionic villi sampling
|
Townsend, Marie
|
|
1990
|
11 |
4 |
p. 267-268
2 p.
|
artikel
|
| 23 |
Design of an RCT of prevention of non-a non-b posttransfusion hepatitis when incidence is decreasing
|
Bull, Shelley
|
|
1990
|
11 |
4 |
p. 268-
1 p.
|
artikel
|
| 24 |
Drug development for AIDS: How much can we get out of phase I?
|
Cross, Anne P.
|
|
1990
|
11 |
4 |
p. 253-
1 p.
|
artikel
|
| 25 |
Early termination of the VA cooperative study of steroid therapy for systemic sepsis
|
Peduzzi, Peter
|
|
1990
|
11 |
4 |
p. 263-
1 p.
|
artikel
|
| 26 |
Efficacy versus intent-to-treat analysis in the canadian American ticlopidine study
|
Roberts, Robin S.
|
|
1990
|
11 |
4 |
p. 259-
1 p.
|
artikel
|
| 27 |
Eleventh annual meeting of the society for clinical trials
|
|
|
1990
|
11 |
4 |
p. 235-252
18 p.
|
artikel
|
| 28 |
Evaluating the need for sending paper forms to the data coordinating center (DCC) in a clinical trial with distributed data entry
|
Gassman, J.J.
|
|
1990
|
11 |
4 |
p. 271-
1 p.
|
artikel
|
| 29 |
Examination of designs for phase I clinical trials
|
Baker, Sherryl A.
|
|
1990
|
11 |
4 |
p. 257-
1 p.
|
artikel
|
| 30 |
Experimental design of the hutchinson smoking prevention project
|
Peterson Jr., Arthur V.
|
|
1990
|
11 |
4 |
p. 269-
1 p.
|
artikel
|
| 31 |
Grouped residuals for proportional hazards models
|
Cnaan, Avital
|
|
1990
|
11 |
4 |
p. 265-266
2 p.
|
artikel
|
| 32 |
Interim analyses for sample size reestimation without unblinding treatment group identification in double-blind clinical trials
|
Shih, Weichung Joseph
|
|
1990
|
11 |
4 |
p. 264-
1 p.
|
artikel
|
| 33 |
Interpreting the effects of mediating variables on blood pressure in the HPT
|
Van Natta, Mark
|
|
1990
|
11 |
4 |
p. 262-263
2 p.
|
artikel
|
| 34 |
Low-tech profile with individualized options for a multinational screening trial
|
Alexander, Sophie
|
|
1990
|
11 |
4 |
p. 256-
1 p.
|
artikel
|
| 35 |
·58 Methodologic issues in a randomized trial to evaluate the effects of omega-3 polyunsaturated fatty acids and low-molecular-weight heparin on restenosis following percutaneous transluminal coronary angioplasty
|
Costantini, Lorrie
|
|
1990
|
11 |
4 |
p. 276-277
2 p.
|
artikel
|
| 36 |
Monitoring and reviewing drug-safety issues in a blinded trial: A sponsor's perspective
|
Goodlow, Janis L.
|
|
1990
|
11 |
4 |
p. 273-
1 p.
|
artikel
|
| 37 |
Must the evaluator be blinded?
|
Noseworthy, J.H.
|
|
1990
|
11 |
4 |
p. 260-261
2 p.
|
artikel
|
| 38 |
NHLBI clinical trials and conflicts of interest
|
Buchwald, Henry
|
|
1990
|
11 |
4 |
p. 217-222
6 p.
|
artikel
|
| 39 |
·P-72 A crossover analysis of the educational benefits of a patient information handbook
|
James, Kenneth E.
|
|
1990
|
11 |
4 |
p. 307-
1 p.
|
artikel
|
| 40 |
·P-73 A directory of clinical trial registries
|
Easterbrook, Philippa J.
|
|
1990
|
11 |
4 |
p. 308-
1 p.
|
artikel
|
| 41 |
·P-22 A graphic method for evaluating effects of treatment oncardiac arrhythmias
|
Dies, Federico
|
|
1990
|
11 |
4 |
p. 286-
1 p.
|
artikel
|
| 42 |
·P-44 A microcomputer-based patient tracking system
|
Litwin, Paul E.
|
|
1990
|
11 |
4 |
p. 295-
1 p.
|
artikel
|
| 43 |
·P-56 A model for comparing the efficacy of randomization procedures in controlled clinical trials
|
Chauvin, Franck
|
|
1990
|
11 |
4 |
p. 300-301
2 p.
|
artikel
|
| 44 |
·P-08 An analysis of data collection mechanisms
|
Tyrell, Doris
|
|
1990
|
11 |
4 |
p. 280-
1 p.
|
artikel
|
| 45 |
·P-43 An automated participant-tracking system for clinical trials
|
La Chance, Pierre-Andre
|
|
1990
|
11 |
4 |
p. 295-
1 p.
|
artikel
|
| 46 |
·P-52 An evaluation of human panelists in assessing coronary atherosclerosis
|
Pogoda, Janice
|
|
1990
|
11 |
4 |
p. 299-
1 p.
|
artikel
|
| 47 |
·P-60 Automatic drug replenishment system for multicenter clinical trials
|
Maone, Loretta A.
|
|
1990
|
11 |
4 |
p. 302-303
2 p.
|
artikel
|
| 48 |
·P-48 Biometric issues in measuring and analyzing compliance in clinical trials
|
Hasford, Joerg
|
|
1990
|
11 |
4 |
p. 297-
1 p.
|
artikel
|
| 49 |
·P-03 Capturing cancer clinical trials data at the source and communicating them electronically
|
Welch, Susan Rea
|
|
1990
|
11 |
4 |
p. 278-
1 p.
|
artikel
|
| 50 |
·P-68 Changes in NHLBI guidelines for clinical trials, community-based studies, and demonstration and education projects
|
Monsees Jr., David M.
|
|
1990
|
11 |
4 |
p. 306-
1 p.
|
artikel
|
| 51 |
·P-05 Changing coordinating centers in midtrial: Lessons learned from the IHDP
|
Wilkinson, Patricia
|
|
1990
|
11 |
4 |
p. 279-
1 p.
|
artikel
|
| 52 |
·P-10 Computer-assisted electroretinogram grading
|
Ganguly, Anik
|
|
1990
|
11 |
4 |
p. 281-
1 p.
|
artikel
|
| 53 |
·P-59 Conditional power calculations through computer simulation: An aid to data monitoring
|
Lee, Kelvin K.
|
|
1990
|
11 |
4 |
p. 302-
1 p.
|
artikel
|
| 54 |
·P-70 Coordinating a Pivotal Clinical Trial (PCT): An educational experience
|
Johnston, Dianne B.
|
|
1990
|
11 |
4 |
p. 306-307
2 p.
|
artikel
|
| 55 |
·P-63 Coordination and patient management of a multicenter clinical trial
|
Clark, Karen K.
|
|
1990
|
11 |
4 |
p. 304-
1 p.
|
artikel
|
| 56 |
·P-38 Data management for phase II Studies: The experience of the EORTC data center
|
Van Glabbeke, M.
|
|
1990
|
11 |
4 |
p. 293-
1 p.
|
artikel
|
| 57 |
·P-64 Data top: Managing an accelerated trial
|
Pelusio, Rita M.
|
|
1990
|
11 |
4 |
p. 304-
1 p.
|
artikel
|
| 58 |
·P-39 Design of a distributed data processing system for a large-scale, short-term trial in infectious disease
|
Voynick, Irene M.
|
|
1990
|
11 |
4 |
p. 293-
1 p.
|
artikel
|
| 59 |
·P-28 Determining ineligibility: The role of central review of supporting documentation
|
Sadura, Anna
|
|
1990
|
11 |
4 |
p. 288-289
2 p.
|
artikel
|
| 60 |
·P-04 Development of a lookup table within a sir database: Adapted from ICD★9★cm, for classification of diagnoses
|
Whyte, Jennifer
|
|
1990
|
11 |
4 |
p. 278-279
2 p.
|
artikel
|
| 61 |
·P-47 Difficulty of retrospectively correlating dose with time to response based on a phase II clinical trial
|
Hagerty, C.
|
|
1990
|
11 |
4 |
p. 297-
1 p.
|
artikel
|
| 62 |
·P-49 Does center size affect protocol compliance on multicentered clinical trials (MCCT)? The National Cancer Institute of Canada Clinical Trials Group's (NCIC CTG) experience
|
Loomer, Stephanie
|
|
1990
|
11 |
4 |
p. 297-298
2 p.
|
artikel
|
| 63 |
·P-55 Dosage adjustments in response to monitored plasma concentrations: Can unblinded staff adhere to objective criteria?
|
Todd Sahlroot, J.
|
|
1990
|
11 |
4 |
p. 300-
1 p.
|
artikel
|
| 64 |
·P-62 Drug distribution in a complex multiarm, multidrug trial: The Postmenopausal Estrogen/Progestin Interventions (PEPI) experience
|
Wasilauskas, Carol H.
|
|
1990
|
11 |
4 |
p. 303-
1 p.
|
artikel
|
| 65 |
·P-12 Effects of the omission of known and unknown prognostic covariates on treatment comparison in survival studies
|
Cheveret, Sylvie
|
|
1990
|
11 |
4 |
p. 282-
1 p.
|
artikel
|
| 66 |
·P-69 Effects on patients and staff of altering the protocol of a clinical trial after adverse effects: Experience in the Cardiac Arrhythmia Suppression Trial (CAST)
|
Myles, James
|
|
1990
|
11 |
4 |
p. 306-
1 p.
|
artikel
|
| 67 |
·P-46 Estimating rates of change in randomized studies
|
Laird, N.
|
|
1990
|
11 |
4 |
p. 296-
1 p.
|
artikel
|
| 68 |
·P-42 Experience using a drug database to classify concomitant medications taken during clinical trials
|
Anderson, Gary D.
|
|
1990
|
11 |
4 |
p. 294-295
2 p.
|
artikel
|
| 69 |
·P-01 Impact of a changing computer environment on the operations of a clinical trial
|
Kraska, Edward W.
|
|
1990
|
11 |
4 |
p. 277-
1 p.
|
artikel
|
| 70 |
·P-65 Impact of the monitoring of center performance
|
Koski, Beverly
|
|
1990
|
11 |
4 |
p. 304-305
2 p.
|
artikel
|
| 71 |
·P-07 Industry involvement in cooperative group trials: Effects on data management
|
Paul, Nancy
|
|
1990
|
11 |
4 |
p. 280-
1 p.
|
artikel
|
| 72 |
·P-67 Intermediate drug approval: A proposal for expediting the conduct of randomized clinical trials while containing cost
|
Hallstrom, Alfred P.
|
|
1990
|
11 |
4 |
p. 305-
1 p.
|
artikel
|
| 73 |
·P-16 Interrater variability in pathological classification: Impact on prognosis of non-hodgkin lymphoma
|
Zwingers, T.R.
|
|
1990
|
11 |
4 |
p. 283-284
2 p.
|
artikel
|
| 74 |
·P-17 Investigator effects in a multicenter trial for parkinson's disease
|
Oakes, David
|
|
1990
|
11 |
4 |
p. 284-
1 p.
|
artikel
|
| 75 |
·P-30 Is standardization possible in multicenter clinical trials in which 45 medical centers and 500 clinical professionals are involved: The COMS experience
|
Markowitz, Jan A.
|
|
1990
|
11 |
4 |
p. 289-
1 p.
|
artikel
|
| 76 |
·P-19 Issues in the design and evaluation of a controlled intervention trial to improve the utilization of mammography
|
Gimotty, Phyllis A.
|
|
1990
|
11 |
4 |
p. 285-
1 p.
|
artikel
|
| 77 |
·P-33 Issues in the design of reproducibility studies for quality assurance in clinical trials
|
Jeffreys, Joan L.
|
|
1990
|
11 |
4 |
p. 290-291
2 p.
|
artikel
|
| 78 |
·P-32 Issues in the quality of clinical trial protocols
|
Moher, David
|
|
1990
|
11 |
4 |
p. 290-
1 p.
|
artikel
|
| 79 |
Plans for analysis of the shep trial
|
Wittes, J.
|
|
1990
|
11 |
4 |
p. 267-
1 p.
|
artikel
|
| 80 |
·P-34 Limitations in generalizing results from clinical trials
|
Sabella, Linda R.
|
|
1990
|
11 |
4 |
p. 291-
1 p.
|
artikel
|
| 81 |
·P-53 Methodological guidelines for randomized clinical trials of surgical procedures
|
Kestle, John R.W.
|
|
1990
|
11 |
4 |
p. 299-
1 p.
|
artikel
|
| 82 |
·P-18 Need an endpoint for a clinical trial? Just ask
|
Harrelson-Woodlief, L.
|
|
1990
|
11 |
4 |
p. 284-
1 p.
|
artikel
|
| 83 |
·P-06 Need for selectivity of data collected in clinical trials
|
Julian, Denise
|
|
1990
|
11 |
4 |
p. 279-
1 p.
|
artikel
|
| 84 |
·P-14 Outcome adjudication in an ongoing trial
|
Hewson, Sheila A.
|
|
1990
|
11 |
4 |
p. 283-
1 p.
|
artikel
|
| 85 |
·P-50 Outcome measurements in clinical trials for stroke patients
|
Brown, Eileen
|
|
1990
|
11 |
4 |
p. 298-
1 p.
|
artikel
|
| 86 |
·P-58 Power and sample size calculations: A review and computer program
|
Dupont, William D.
|
|
1990
|
11 |
4 |
p. 301-
1 p.
|
artikel
|
| 87 |
·P-11 Problems developing a disease-specific quality of life measure for multiple sclerosis (MS)
|
Brownscombe, I.
|
|
1990
|
11 |
4 |
p. 281-
1 p.
|
artikel
|
| 88 |
·P-29 Problems in initiating recruitment in a clinical trial
|
Margitic, Susan E.
|
|
1990
|
11 |
4 |
p. 289-
1 p.
|
artikel
|
| 89 |
·P-37 Proteo: An expert system for quality control of patient's eligibility criteria in clinical trials
|
De Rosa, M.
|
|
1990
|
11 |
4 |
p. 292-
1 p.
|
artikel
|
| 90 |
·P-25 Recruitment strategies: Studies of left ventricular dysfunction (SOLVD)
|
Dierenfeldt, Barbara
|
|
1990
|
11 |
4 |
p. 287-
1 p.
|
artikel
|
| 91 |
Prerandomization drug withdrawal-yield and process: The SHEP trial
|
SHEP Cooperative Group,
|
|
1990
|
11 |
4 |
p. 256-
1 p.
|
artikel
|
| 92 |
·P-57 Sample size for trials where survival depends on first response rates
|
Zee, Benny
|
|
1990
|
11 |
4 |
p. 301-
1 p.
|
artikel
|
| 93 |
·P-23 Screening and recruitment for the systolic hypertension in the elderly program (SHEP)
|
Petrovitch, Helen
|
|
1990
|
11 |
4 |
p. 286-
1 p.
|
artikel
|
| 94 |
PSM/PRS: Micro to mainframe system for protocol selection, eligibility checking and randomization
|
Zicarelli, T.
|
|
1990
|
11 |
4 |
p. 270-271
2 p.
|
artikel
|
| 95 |
·P-24 Staffing patterns and recruitment strategies in systolic hypertension in the elderly program (SHEP)
|
Cosgrove, Nora
|
|
1990
|
11 |
4 |
p. 287-
1 p.
|
artikel
|
| 96 |
·P-31 Structure, function, and costs of site visits
|
Fink, Nancy E.
|
|
1990
|
11 |
4 |
p. 290-
1 p.
|
artikel
|
| 97 |
·P-27 Systems of logging exclusions in multicenter clinical trials
|
Seip, Annette
|
|
1990
|
11 |
4 |
p. 288-
1 p.
|
artikel
|
| 98 |
·P-66 Testing protocol knowledge of clinic coordinators
|
Boone, Donna C.
|
|
1990
|
11 |
4 |
p. 305-
1 p.
|
artikel
|
| 99 |
·P-21 The analysis of a complex dental study with repeated measures
|
Anderson, Robert J.
|
|
1990
|
11 |
4 |
p. 285-286
2 p.
|
artikel
|
| 100 |
·P-45 The datafax project
|
Wayne Taylor, D.
|
|
1990
|
11 |
4 |
p. 296-
1 p.
|
artikel
|
| 101 |
·P-20 The healthy responder effect in nonrandomized clinical trials: An example from the cardiac arrhythmia suppression trial
|
Hallstrom, Alfred P.
|
|
1990
|
11 |
4 |
p. 285-
1 p.
|
artikel
|
| 102 |
·P-35 The impact of management guidelines on quality of breast, colorectal and ovarian cancer in community hospitals
|
Grilli, R.
|
|
1990
|
11 |
4 |
p. 291-
1 p.
|
artikel
|
| 103 |
·P-15 The operation of a central adjudication committee and its effect of the validity of the assessment of treatment benefit
|
Sicurella, Jane
|
|
1990
|
11 |
4 |
p. 283-
1 p.
|
artikel
|
| 104 |
·P-71 The reluctance of physicians to recommend clinical trials: Factors that may affect the attractiveness of trials for physicians
|
Siminoff, Laura A.
|
|
1990
|
11 |
4 |
p. 307-
1 p.
|
artikel
|
| 105 |
·P-13 The requirements of a multicentered clinical trial designed to evaluate spinal implants: Industry and FDA perspectives
|
Carlow, John J.
|
|
1990
|
11 |
4 |
p. 282-
1 p.
|
artikel
|
| 106 |
·P-41 The UNIX operating system in the clinical trials environment
|
Yetisir, Elizabeth
|
|
1990
|
11 |
4 |
p. 294-
1 p.
|
artikel
|
| 107 |
·P-54 Training Levels Comparison (TLC) trial: Design issues
|
Lee, Jeannette
|
|
1990
|
11 |
4 |
p. 300-
1 p.
|
artikel
|
| 108 |
·P-26 Trends in patient accrual rates by clinical center over a 10-year period
|
Blackhurst, Dawn W.
|
|
1990
|
11 |
4 |
p. 287-288
2 p.
|
artikel
|
| 109 |
·P-51 Trial implementation rating scale
|
Taylor, Kathryn M.
|
|
1990
|
11 |
4 |
p. 298-
1 p.
|
artikel
|
| 110 |
·P-02 Use of a computerized data audit system to increase the quality of data in a long-term multicenter trial (LTMT)
|
Brown, Mary W.
|
|
1990
|
11 |
4 |
p. 277-278
2 p.
|
artikel
|
| 111 |
·P-09 Use of an external lookup table for coding textual data
|
Nelson, Harvey
|
|
1990
|
11 |
4 |
p. 280-281
2 p.
|
artikel
|
| 112 |
·P-40 Utilizing the relational database data dictionary for applications
|
LoPresti, Fran
|
|
1990
|
11 |
4 |
p. 294-
1 p.
|
artikel
|
| 113 |
·P-36 VA Cooperative Studies Program: A registry of studies conducted since the program's inception
|
Weiss, David G.
|
|
1990
|
11 |
4 |
p. 292-
1 p.
|
artikel
|
| 114 |
Randomization in clinical trials through a computerized network: Does it improve the data quality?
|
Renard, Josette
|
|
1990
|
11 |
4 |
p. 270-
1 p.
|
artikel
|
| 115 |
Reasons for declining participation in a prospective randomized trial to determine the optimum mode of delivery of the preterm breech
|
Penn, Zoe J.
|
|
1990
|
11 |
4 |
p. 226-231
6 p.
|
artikel
|
| 116 |
Recruitment of infants for randomized clinical trial
|
Collet, Jean-Paul
|
|
1990
|
11 |
4 |
p. 257-
1 p.
|
artikel
|
| 117 |
Resampling methods for repeated measures in clinical trials
|
Evans, Gregory W.
|
|
1990
|
11 |
4 |
p. 261-
1 p.
|
artikel
|
| 118 |
Risk factors for publications bias: Results of a follow-up study
|
Dickersin, Kay
|
|
1990
|
11 |
4 |
p. 255-
1 p.
|
artikel
|
| 119 |
Sampling design of multiwave studies with an application to the Massachusetts health care panel study
|
Chappell, Rick
|
|
1990
|
11 |
4 |
p. 257-258
2 p.
|
artikel
|
| 120 |
Selection bias in a randomized controlled clinical trial
|
Stangl, Dalene
|
|
1990
|
11 |
4 |
p. 258-
1 p.
|
artikel
|
| 121 |
Significance tests of covariate imbalance in clinical trials
|
Begg, Colin B.
|
|
1990
|
11 |
4 |
p. 223-225
3 p.
|
artikel
|
| 122 |
Statistical design of the postmenopausal estrogen/progestin intervention trial
|
Espeland, Mark A.
|
|
1990
|
11 |
4 |
p. 263-
1 p.
|
artikel
|
| 123 |
Statistical issues in monitoring a 2 × 2 factorial clinical trial
|
Jackson Hall, W.
|
|
1990
|
11 |
4 |
p. 264-
1 p.
|
artikel
|
| 124 |
Study duration for stratified clinical trials with survival data and early stopping rule
|
Kim, Krungmann
|
|
1990
|
11 |
4 |
p. 265-
1 p.
|
artikel
|
| 125 |
The analysis of failure time data in crossover studies
|
Lewis, John A.
|
|
1990
|
11 |
4 |
p. 266-
1 p.
|
artikel
|
| 126 |
The design of a meta-analysis collecting individual patient data in advanced ovarian cancer
|
Stewart, Lesley
|
|
1990
|
11 |
4 |
p. 255-
1 p.
|
artikel
|
| 127 |
The early termination, for harm, of a major clinical trial
|
Verter, Joel
|
|
1990
|
11 |
4 |
p. 274-
1 p.
|
artikel
|
| 128 |
The effect of partial noncompliance of the power of a cancer prevention clinical trial
|
Freedman, Laurence S.
|
|
1990
|
11 |
4 |
p. 269-270
2 p.
|
artikel
|
| 129 |
The impact of stopping rules on meta-analyses
|
Pocock, Stuart J.
|
|
1990
|
11 |
4 |
p. 254-
1 p.
|
artikel
|
| 130 |
The statistical analysis of causes of death in randomized clinical trials
|
Buyse, Marc
|
|
1990
|
11 |
4 |
p. 265-
1 p.
|
artikel
|
| 131 |
The timing of important events surrounding the emergent (4/19/89) alteration of a clinical trial: The cardiac arrhythmia suppression trial (CAST)
|
Myles, James
|
|
1990
|
11 |
4 |
p. 274-
1 p.
|
artikel
|
| 132 |
To blind…or not to blind?
|
Colling, Cindy L.
|
|
1990
|
11 |
4 |
p. 260-
1 p.
|
artikel
|
| 133 |
Tracking, accessing, and reporting on edit queries
|
Connor, Paul B.
|
|
1990
|
11 |
4 |
p. 272-
1 p.
|
artikel
|
| 134 |
Two methods for comparing staging systems for chronic diseases
|
Benichou, Jacques
|
|
1990
|
11 |
4 |
p. 266-267
2 p.
|
artikel
|
| 135 |
·59 Using state of death to identify false-positive national death index matches
|
Evans, Gregory W.
|
|
1990
|
11 |
4 |
p. 277-
1 p.
|
artikel
|
| 136 |
Were the results of cast due to drug packaging error?
|
Haakenson, Clair
|
|
1990
|
11 |
4 |
p. 272-
1 p.
|
artikel
|
Tijdschrift beschrijving